{"id":"W4306941118","doi":"10.1038/s41375-022-01724-9","title":"Finding consistency in classifications of myeloid neoplasms: a perspective on behalf of the International Workshop for Myelodysplastic Syndromes","year":2022,"lang":"en","type":"letter","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Takeda Oncology; Genentech; National Institutes of Health; Astellas Pharma; Pfizer; Incyte; CTI Biopharma; bluebird bio; Agios Pharmaceuticals; Syndax Pharmaceuticals; National Heart, Lung, and Blood Institute; Edward P. Evans Foundation; Acceleron; Astex Pharmaceuticals; Daiichi-Sankyo; MacroGenics; Celldex Therapeutics; Jazz Pharmaceuticals; Leukemia and Lymphoma Society; Apellis Pharmaceuticals; Alexion Pharmaceuticals; Daiichi Sankyo Europe; Servier; Aplastic Anemia and MDS International Foundation; Gilead Sciences; BioCryst; Celgene; Bristol-Myers Squibb; AstraZeneca; Cardinal Health; Amgen; American Cancer Society","keywords":"Myelodysplastic syndromes; Consistency (knowledge bases); Medicine; Myeloid; Perspective (graphical); Oncology; Myeloid leukemia; Internal medicine; Immunology; Computer science; Bone marrow; Artificial intelligence","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0004313339,0.0003565763,0.0008157946,0.0009255766,0.0001360024,0.00002105361,0.0009993986,0.0005772301,0.0006486423],"category_scores_gemma":[0.002732433,0.0002902959,0.0004651299,0.0008031832,0.0004403485,0.00005917266,0.0003333278,0.003258628,0.00001176077],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.008796448,"about_ca_system_score_gemma":0.003997591,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002983596,"about_ca_topic_score_gemma":0.00006513027,"domain_scores_codex":[0.9967012,0.0001576226,0.000826861,0.0006717333,0.001168167,0.0004743596],"domain_scores_gemma":[0.9949971,0.002966761,0.000590309,0.0009281827,0.0004578507,0.00005972946],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001097231,0.0002296571,0.002737283,0.001019443,0.0009970156,0.0003048009,0.002725561,0.0004540713,0.002134232,0.006144552,0.9815025,0.0006536858],"study_design_scores_gemma":[0.01902603,0.002710573,0.0368657,0.007976375,0.001987488,0.001265873,0.02061774,0.008976668,0.005308636,0.00427889,0.8890439,0.001942176],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.117216,0.0004254726,0.0001990068,0.84681,0.002212463,0.004803116,0.001765662,0.00007835641,0.02648989],"genre_scores_gemma":[0.8256996,0.0002374834,0.002193516,0.1198228,0.002160813,0.002545825,0.001660614,0.0003695996,0.04530982],"genre_candidate":"commentary","genre_consensus":null,"teacher_disagreement_score":0.7269872,"threshold_uncertainty_score":0.9999549,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0518485078356917,"score_gpt":0.327909335146388,"score_spread":0.2760608273106964,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}